Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Julio D Duarte

Showing results (51-60 of 72) with videos related to

Pageof 8
Sort By:
Arteriosclerosis, Thrombosis, and Vascular Biology|May 30, 2024
Plasma Proteomics Identifies B2M as a Regulator of Pulmonary Hypertension in Heart Failure With Preserved Ejection FractionJia-Rong Jheng, Jacqueline T DesJardin, Yi-Yun Chen, et al.
Journal of Translational Medicine|March 24, 2012
Effects of genetic variation in H3K79 methylation regulatory genes on clinical blood pressure and blood pressure response to hydrochlorothiazideJulio D Duarte, Issam Zineh, Ben Burkley, et al.
Pharmacotherapy|July 19, 2013
Feasibility of implementing a comprehensive warfarin pharmacogenetics serviceEdith A Nutescu, Katarzyna Drozda, Adam P Bress, et al.
Clinical and Translational Science|October 29, 2021
β1-receptor polymorphisms and junctional ectopic tachycardia in children after cardiac surgeryLeanne Dumeny, Marut Chantra, Taimour Langaee, et al.
Clinical and Translational Science|December 28, 2025
Global Investigation of Clinical Implementation Strategies for DPYD Testing to Guide Fluoropyrimidine TherapyNihal El Rouby, Christina L Aquilante, Salma A Bargal, et al.
Clinical Pharmacology and Therapeutics|August 28, 2025
Impact of Race on Profiles of Platelet Reactivity and Clinical Outcomes in Clopidogrel-Treated ParticipantsLuis Ortega-Paz, Cameron D Thomas, Claudio Laudani, et al.
Clinical Pharmacology and Therapeutics|June 12, 2023
An Introductory Tutorial on Cardiovascular Pharmacogenetics for Healthcare ProvidersAkinyemi Oni-Orisan, Sony Tuteja, Glenda Hoffecker, et al.
Journal of the American Heart Association|July 4, 2025
<i>CYP2C19</i> Phenotype, P2Y<sub>12</sub> Inhibitor Selection, and Clinical Outcomes in Patients on Maintenance Clopidogrel TherapyRajiv C Patel, Cameron D Thomas, Joseph S Rossi, et al.
The Pharmacogenomics Journal|February 12, 2020
Cost-effectiveness of CYP2C19-guided antiplatelet therapy in patients with acute coronary syndrome and percutaneous coronary intervention informed by real-world dataNita A Limdi, Larisa H Cavallari, Craig R Lee, et al.
Clinical and Translational Science|July 10, 2026
Machine Learning With Genetic and Clinical Data to Predict Ischemic Outcomes After PCICaroline W Grant, Brenden S Ingraham, Ryan J Lennon, et al.
Pageof 8

Showing results (51-60 of 72) with videos related to

Sort By:
Pageof 8
Arteriosclerosis, Thrombosis, and Vascular Biology|May 30, 2024
Plasma Proteomics Identifies B2M as a Regulator of Pulmonary Hypertension in Heart Failure With Preserved Ejection FractionJia-Rong Jheng, Jacqueline T DesJardin, Yi-Yun Chen, et al.
Journal of Translational Medicine|March 24, 2012
Effects of genetic variation in H3K79 methylation regulatory genes on clinical blood pressure and blood pressure response to hydrochlorothiazideJulio D Duarte, Issam Zineh, Ben Burkley, et al.
Pharmacotherapy|July 19, 2013
Feasibility of implementing a comprehensive warfarin pharmacogenetics serviceEdith A Nutescu, Katarzyna Drozda, Adam P Bress, et al.
Clinical and Translational Science|October 29, 2021
β1-receptor polymorphisms and junctional ectopic tachycardia in children after cardiac surgeryLeanne Dumeny, Marut Chantra, Taimour Langaee, et al.
Clinical and Translational Science|December 28, 2025
Global Investigation of Clinical Implementation Strategies for DPYD Testing to Guide Fluoropyrimidine TherapyNihal El Rouby, Christina L Aquilante, Salma A Bargal, et al.
Clinical Pharmacology and Therapeutics|August 28, 2025
Impact of Race on Profiles of Platelet Reactivity and Clinical Outcomes in Clopidogrel-Treated ParticipantsLuis Ortega-Paz, Cameron D Thomas, Claudio Laudani, et al.
Clinical Pharmacology and Therapeutics|June 12, 2023
An Introductory Tutorial on Cardiovascular Pharmacogenetics for Healthcare ProvidersAkinyemi Oni-Orisan, Sony Tuteja, Glenda Hoffecker, et al.
Journal of the American Heart Association|July 4, 2025
<i>CYP2C19</i> Phenotype, P2Y<sub>12</sub> Inhibitor Selection, and Clinical Outcomes in Patients on Maintenance Clopidogrel TherapyRajiv C Patel, Cameron D Thomas, Joseph S Rossi, et al.
The Pharmacogenomics Journal|February 12, 2020
Cost-effectiveness of CYP2C19-guided antiplatelet therapy in patients with acute coronary syndrome and percutaneous coronary intervention informed by real-world dataNita A Limdi, Larisa H Cavallari, Craig R Lee, et al.
Clinical and Translational Science|July 10, 2026
Machine Learning With Genetic and Clinical Data to Predict Ischemic Outcomes After PCICaroline W Grant, Brenden S Ingraham, Ryan J Lennon, et al.
Pageof 8